Selective Wealth Management’s Gilead Sciences GILD Stock Holding History

Selective Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18	Closed	-$1K	–	349
2022 Q3	$1K	Buy	+18	New	+$1.14K	﹤0.01%	723
2021 Q2	–	Sell	-100	Closed	-$6K	–	519
2021 Q1	$6K	Hold	100	–	–	0.01%	296
2020 Q4	$6K	Hold	100	–	–	﹤0.01%	280
2020 Q3	$6K	Sell	100 -85	-46%	-$5.89K	﹤0.01%	238
2020 Q2	$15K	Hold	185	–	–	0.01%	203
2020 Q1	$13K	Hold	185	–	–	0.02%	136
2019 Q4	$12K	Buy	185 +1	+0.5%	+$65	0.01%	149
2019 Q3	$11K	Buy	+184	New	+$12K	0.02%	162
2018 Q3	$15K	Buy	+200	New	+$15.1K	0.18%	67

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Selective Wealth Management's GILD Position: Q4 2022 in Review

Selective Wealth Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 18 shares — an estimated $1K sold.

Selective Wealth Management first reported a position in GILD in Q3 2018 and held it in 9 quarters. The position peaked at $15K in Q2 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Selective Wealth Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
Selective Wealth Management sold 18 Gilead Sciences shares in Q4 2022, an estimated $1K.
Selective Wealth Management first reported a position in Gilead Sciences in Q3 2018 and held it in 9 quarters.
Selective Wealth Management's Gilead Sciences position peaked at $15K in Q2 2020.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Selective Wealth Management's 13F filing for Q4 2022, filed 23 Jan 2023.